These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36867517)

  • 1. Biomarkers for Bile Acid Malabsorption in Diarrhea-predominant Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.
    Liu T; Ma M; Li K; Tan W; Yu H; Wang L
    J Clin Gastroenterol; 2023 May-Jun 01; 57(5):451-458. PubMed ID: 36867517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.
    Riemsma R; Al M; Corro Ramos I; Deshpande SN; Armstrong N; Lee YC; Ryder S; Noake C; Krol M; Oppe M; Kleijnen J; Severens H
    Health Technol Assess; 2013 Dec; 17(61):1-236. PubMed ID: 24351663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of Bile Acid Metabolism in Pediatric Diarrhea Predominant Irritable Bowel Syndrome and Healthy Controls.
    Beinvogl BC; Manini ML; Camilleri M; Donato LJ; Harmsen WS; Absah I; Burch E; Schechter NL; Nurko S
    J Pediatr Gastroenterol Nutr; 2021 Jun; 72(6):859-865. PubMed ID: 33976086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea.
    Slattery SA; Niaz O; Aziz Q; Ford AC; Farmer AD
    Aliment Pharmacol Ther; 2015 Jul; 42(1):3-11. PubMed ID: 25913530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.
    Kurien M; Evans KE; Leeds JS; Hopper AD; Harris A; Sanders DS
    Scand J Gastroenterol; 2011 Jul; 46(7-8):818-22. PubMed ID: 21492055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome.
    Wedlake L; A'Hern R; Russell D; Thomas K; Walters JR; Andreyev HJ
    Aliment Pharmacol Ther; 2009 Oct; 30(7):707-17. PubMed ID: 19570102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
    Walters JR; Tasleem AM; Omer OS; Brydon WG; Dew T; le Roux CW
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1189-94. PubMed ID: 19426836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for diagnosis of bile acid malabsorption in clinical practice.
    Vijayvargiya P; Camilleri M; Shin A; Saenger A
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1232-9. PubMed ID: 23644387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
    Battat R; Duijvestein M; Vande Casteele N; Singh S; Dulai PS; Valasek MA; Mimms L; McFarland J; Hester KD; Renshaw M; Jain A; Sandborn WJ; Boland BS
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2722-2730.e4. PubMed ID: 30448597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.
    Vijayvargiya P; Busciglio I; Burton D; Donato L; Lueke A; Camilleri M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):522-527. PubMed ID: 28666948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for diagnosing bile acid malabsorption: a systematic review.
    Lyutakov I; Ursini F; Penchev P; Caio G; Carroccio A; Volta U; De Giorgio R
    BMC Gastroenterol; 2019 Nov; 19(1):185. PubMed ID: 31726982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea.
    Wong BS; Camilleri M; Carlson P; McKinzie S; Busciglio I; Bondar O; Dyer RB; Lamsam J; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2012 Sep; 10(9):1009-15.e3. PubMed ID: 22610000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.
    Vijayvargiya P; Camilleri M; Carlson P; Lueke A; O'Neill J; Burton D; Busciglio I; Donato L
    Aliment Pharmacol Ther; 2017 Sep; 46(6):581-588. PubMed ID: 28691284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of serum 7alpha-hydroxy-4-cholesten-3-one (or 7alphaC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry.
    Camilleri M; Nadeau A; Tremaine WJ; Lamsam J; Burton D; Odunsi S; Sweetser S; Singh R
    Neurogastroenterol Motil; 2009 Jul; 21(7):734-e43. PubMed ID: 19368662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bile and fat excretion are biomarkers of clinically significant diarrhoea and constipation in irritable bowel syndrome.
    Vijayvargiya P; Camilleri M; Burton D; Busciglio I; Lueke A; Donato LJ
    Aliment Pharmacol Ther; 2019 Mar; 49(6):744-758. PubMed ID: 30740753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.
    Peleman C; Camilleri M; Busciglio I; Burton D; Donato L; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2017 May; 15(5):720-727.e1. PubMed ID: 27856362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Fecal Microbiomes and Metabolomes of People With vs Without Irritable Bowel Syndrome and Bile Acid Malabsorption.
    Jeffery IB; Das A; O'Herlihy E; Coughlan S; Cisek K; Moore M; Bradley F; Carty T; Pradhan M; Dwibedi C; Shanahan F; O'Toole PW
    Gastroenterology; 2020 Mar; 158(4):1016-1028.e8. PubMed ID: 31843589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.
    Camilleri M; Busciglio I; Acosta A; Shin A; Carlson P; Burton D; Ryks M; Rhoten D; Lamsam J; Lueke A; Donato LJ; Zinsmeister AR
    Am J Gastroenterol; 2014 Oct; 109(10):1621-30. PubMed ID: 25070056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 7-alfa-hydroxy-4-cholesten-3-one and fibroblast growth factor-19 as biomarkers diagnosing bile acid malabsorption in microscopic colitis and inflammatory bowel disease.
    Lyutakov I; Lozanov V; Sugareva P; Valkov H; Penchev P
    Eur J Gastroenterol Hepatol; 2021 Mar; 33(3):380-387. PubMed ID: 33177381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
    Pattni SS; Brydon WG; Dew T; Johnston IM; Nolan JD; Srinivas M; Basumani P; Bardhan KD; Walters JR
    Aliment Pharmacol Ther; 2013 Oct; 38(8):967-76. PubMed ID: 23981126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.